|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/64 | (2006.01) |
| C12Y 304/24087 | (2013.01) | ||
| C12M 47/12 | (2013.01) | ||
| C12N 11/14 | (2013.01) | ||
| C12N 9/6489 | (2013.01) | ||
| A61P 7/02 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Number of the document | 3211077 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17155619.4 |
| Date of filing the European patent application | 2010-08-02 | |
| (97) | Date of publication of the European application | 2017-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2024-09-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 230308 P | 2009-07-31 | US |
| (72) |
Hasslacher, Meinhard , AT
Mitterer, Artur , AT
Fiedler, Christian , AT
Mayer, Christa , AT
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | METHODS OF PURIFYING RECOMBINANT ADAMTS13 AND OTHER PROTEINS AND COMPOSITIONS THEREOF |
| METHODS OF PURIFYING RECOMBINANT ADAMTS13 AND OTHER PROTEINS AND COMPOSITIONS THEREOF |